Abstract
BackgroundPostnatal dexamethasone (DXM) is widely used to treat preterm infants at risk for bronchopulmonary dysplasia. Previously, it was reported that high-dose DXM leads to deteriorated quality of general movements (GMs)....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have